FDA approves Botox competitor that lasts longer
People wanting to keep wrinkles at bay will soon have a new option now that the U.S. Food and Drug Administration has approved the first competitor for Botox in decades.
Sep 9, 2022
0
17
People wanting to keep wrinkles at bay will soon have a new option now that the U.S. Food and Drug Administration has approved the first competitor for Botox in decades.
Sep 9, 2022
0
17
You might know botulinum toxin as Botox: one of many brand names for the injectable drug that smooths wrinkles and facial creases. What you might not know is that botulinum toxin can also be used to treat migraines and ease ...
Jun 14, 2021
0
3
While it's often hard to appreciate our aging skin, it does tell a story. It speaks of our family heritage: Genetic code mostly drives the development of lines. It can also say something about our lives, like how we enjoyed ...
May 12, 2021
0
4
When people hear botulinum toxin, they often think one of two things: a cosmetic that makes frown lines disappear or a deadly poison.
Feb 24, 2021
0
47
CytoDel, Inc., a privately-held corporation, today announces the publication of preclinical data on the company's lead product, Cyto-111, in the peer-reviewed journal, Science Translational Medicine.
Jan 6, 2021
0
2
Pelvic pain associated with endometriosis often becomes chronic and can persist (or recur) following surgical and hormonal interventions. According to results published in Regional Anesthesia & Pain Medicine, treating pelvic ...
Jul 11, 2019
0
1
(HealthDay)—More than 17.7 million surgical and minimally invasive cosmetic procedures were performed in the United States in 2018, with an increasing trend seen in body-shaping procedures, according to a report published ...
Mar 11, 2019
0
3
A growing body of evidence supports the effectiveness of botulinum toxin injections in reducing the frequency of chronic migraine headaches, concludes an updated review and analysis in the January issue of Plastic and Reconstructive ...
Jan 3, 2019
0
0
(HealthDay)—About 15 percent of patients treated with botulinum toxin type A (BoNT/A) for dystonia or spasticity can develop an immune response to the treatment itself, according to a study published online Nov. 21 in Neurology.
Dec 12, 2018
0
0
Postoperative atrial fibrillation (POAF) is a common complication, affecting one quarter to one half of all patients following cardiac surgery. It can result in heart failure, stroke, and longer hospital stays, resulting ...
Nov 27, 2018
0
2